Letter to the Editor: Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer

Thyroid. 2021 Oct;31(10):1603-1604. doi: 10.1089/thy.2021.0144. Epub 2021 Sep 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Drug Synergism
  • Female
  • Gene Rearrangement / genetics*
  • Humans
  • Iodine Radioisotopes / metabolism
  • Iodine Radioisotopes / therapeutic use*
  • Lymph Node Excision
  • Neoplasm Recurrence, Local / genetics*
  • Neoplasm Recurrence, Local / therapy*
  • Nuclear Receptor Coactivators / genetics
  • Oncogene Proteins, Fusion / genetics
  • Proto-Oncogene Proteins c-ret / genetics*
  • Pyrazoles / pharmacology*
  • Pyrazoles / therapeutic use*
  • Pyridines / pharmacology*
  • Pyridines / therapeutic use*
  • Radiopharmaceuticals / metabolism
  • Radiopharmaceuticals / therapeutic use*
  • Thyroid Cancer, Papillary / genetics*
  • Thyroid Cancer, Papillary / metabolism
  • Thyroid Cancer, Papillary / therapy*
  • Thyroid Neoplasms / genetics*
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / therapy*
  • Thyroidectomy

Substances

  • Iodine Radioisotopes
  • NCOA4 protein, human
  • Nuclear Receptor Coactivators
  • Oncogene Proteins, Fusion
  • Pyrazoles
  • Pyridines
  • Radiopharmaceuticals
  • selpercatinib
  • Proto-Oncogene Proteins c-ret
  • RET protein, human